Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02741102 · ClinicalTrials.gov registry record · Phase 2
Uterine Transplant in Absolute Uterine Infertility (AUIF)
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02741102 is a Phase 2 study that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 3 participants.
The verdict
NCT02741102, a Phase 2 study, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will examine the feasibility of initiating a uterine transplant program for Absolute Uterine Factor Infertility (AUFI) at Brigham and Women's Hospital. The investigators plan to screen 30 patients with a goal of enrolling 10 patients. (5 donors and 5 recipients) After careful screening, appropriate candidates will undergo IVF, Uterine Transplantation, Embryo Transfer, Pregnancy and Delivery. Once the uterus is explanted, five years of follow-up is planned.
Interventions
- PROCEDURE Uterine Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02741102
The ClinicalTrials.gov registry entry for NCT02741102 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Uterine Transplant is the first listed.
NCT02741102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02741102 about?
NCT02741102 is a clinical study titled "Uterine Transplant in Absolute Uterine Infertility (AUIF)". This study will examine the feasibility of initiating a uterine transplant program for Absolute Uterine Factor Infertility (AUFI) at Brigham and Women's Hospital. The investigators plan to screen 30 patients with a goal of enrolling 10 patients. (5 donors and 5 recipients) After careful screening, a...
What is the current status of trial NCT02741102?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2026-07. Estimated completion is 2028-01.
What interventions are being tested in trial NCT02741102?
The interventions under investigation include: Uterine Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT02741102?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.